An interventional study of GEMPO Electronic Education in Fathers' Self-Efficacy and Ability in Newborn Care, sponsored by Musnaini Musnaini. Not yet recruiting at 1 site in Indonesia. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Musnaini Musnaini · Not applicable, Interventional, and Other
This study aims to evaluate the effectiveness of GEMPO (Holding, Bathing, and Diaper Changing) e-education on fathers' self-efficacy and ability to care for newborns. The study will involve fathers of newborns aged 0-28 days. Fathers in the intervention group will receive GEMPO e-education, while fathers in the control group will receive routine or standard health education. Self-efficacy and newborn care abilities will be measured before and after the intervention. The findings are expected to provide information on the role of electronic education in supporting fathers' involvement and skills in newborn care.
This study will evaluate the effectiveness of GEMPO (Holding, Bathing, and Diaper Changing) e-education on fathers' self-efficacy and ability in newborn care.
The study will use a Cluster Randomized Controlled Trial design with a pretest-posttest control group. The study will be conducted in four community health centers in Pekanbaru, Riau, Indonesia: Puskesmas Rumbai, Puskesmas Rumbai Bukit, Puskesmas Umban Sari, and Puskesmas Karya Wanita.
The study population will consist of fathers who have newborns aged 0-28 days and meet the eligibility criteria. The health centers will be randomly allocated to the intervention or control group. Participants in the intervention group will receive GEMPO e-education covering holding, bathing, and diaper changing for newborns. Participants in the control group will receive routine or standard education provided by the health facilities without the GEMPO e-education video.
Fathers' self-efficacy and ability in newborn care will be assessed before and after the intervention. The study will compare changes in these outcomes within and between the intervention and control groups to evaluate the effectiveness of GEMPO e-education.
This is the only study on the registry with Musnaini Musnaini as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the intervention group will receive GEMPO e-education, consisting of educational materials and an approximately -15 minute video covering newborn holding, bathing, and diaper changing techniques. The educational materials will be delivered through WhatsApp with access to the video via YouTube. Fathers' self-efficacy and ability in newborn care will be assessed before and after the intervention.
Behavioral: GEMPO Electronic Education
Participants assigned to the control group will receive routine health education according to the standard procedures of the health facilities. Fathers' self-efficacy and ability in newborn care will be assessed before and after the study period.
GEMPO Electronic Education is an educational intervention for fathers of newborns aged 0-28 days. The intervention provides educational materials and videos on three essential newborn care skills: holding a newborn, bathing a newborn, and changing a newborn's diaper. The educational materials are delivered electronically via WhatsApp. Participants receive the educational content according to the study protocol, with evaluation conducted to assess the outcomes specified in the research protocol.
Fathers' Self-Efficacy in Newborn Care
Self-efficacy score of fathers in performing essential newborn care, assessed using the study-specified instrument. The outcome is evaluated by comparing scores before and after the intervention.
Time frame: Baseline before intervention and immediately after completion of the intervention.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Nov 2026, 1 month later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.